Back to search

Peptide record

TPDB43132

Sample Peptide 6 from US011339203B2 Anticancer standard
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43132
Sample Peptide 6 from US011339203B2
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 34-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
VIIVLSVFIACWAPLFILLLLKKRTLRKNDRKKR-NH2
Physicochemical Analysis
C193H331N53O40S1
EQGHMY
L
4066.14
12.01
9
1
19
+8
0.92
0.600
157.65
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
5500
135.26
4
Residue Composition
number
2
A
4
R
1
N
1
D
1
C
0
E
0
Q
0
G
0
H
4
I
7
L
5
K
0
M
2
F
1
P
1
S
1
T
1
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 4 N: 1 D: 1 C: 1 E: 0 Q: 0 G: 0 H: 0 I: 4 L: 7 K: 5 M: 0 F: 2 P: 1 S: 1 T: 1 W: 1 Y: 0 V: 3
Chemical Descriptors
34
C193H331N53O40S1
4066.14
12.01
+8
0.92
0.600
Amidation
L
Linear
Free
Anticancer
Synthetic
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell Viability
Cell Viability = 59.7% at 25 µM
Anticancer

Target

Renal Cancer
CAKI-2
Kidney

Assay & Model

CCK-8 assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022
US011339203B2

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.